Riskpilot← Back to searchSign inGet full accessCellufy AB
ABActiveOrg 5593969073Teknikringen 38 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20225-9 employees
Revenue 2024
SEK 1,2M
+553% vs 2023
EBITDA margin
71.0%
+1123% vs 2023
Equity ratio
32.6%
Financial strength
Net profit 2024
SEK 524K
+908% vs 2023
| Revenue | SEK 1,2M | +553% |
| EBITDA | SEK 880K | +1123% |
| Net profit | SEK 524K | +908% |
| Total assets | SEK 1,9M | +25% |
| Equity | SEK 621K | +541% |
| Employees | — | — |
Legal name
Cellufy AB
Org number
5593969073
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
15 september 2022
Share capital
SEK 45 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Rostami, Jowan Östmans, Rebecca Anna Mikaela
Company purpose
Aktiebolaget ska bedriva utveckling, tillverkning och marknadsföring av teknologi, processer och material baserade på cellulosa samt därmed förenlig verksamhet såsom konsulttjänster.
Address
Teknikringen 38 A
Email
info@cellufy.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 190 | 1 240 |
| Staff expenses | — | −507 |
| EBITDA | 72 | 880 |
| Depreciation & amort. | −0 | — |
| EBIT | 72 | 880 |
| Net financials | −3 | 3 |
| Profit before tax | 68 | 663 |
| Tax | −16 | −139 |
| Net profit | 52 | 524 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 1 520 | 1 907 |
| Equity | 97 | 621 |
| Long-term debt | 0 | — |
| Short-term debt | 1 423 | 1 066 |
| Total debt | 1 423 | 1 066 |
EBITDA margin
71.0%
This company
15.8%
Market median
+349% vs market
20232024
Equity ratio
32.6%
This company
38.2%
Market median
+15% vs market
20232024
Return on equity
84.3%
This company
18.4%
Market median
+358% vs market
20232024
Net profit margin
42.3%
This company
8.1%
Market median
+422% vs market
20232024
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20232024
Debt / equity
2.07×
This company
0.62×
Market median
-234% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LG Chief Auditor | Chief Auditor | 2024 |
JR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
FA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cellufy AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Gustav Rantatalo | Chief Auditor | 0 companies |
| Jowan Rostami | Chief Executive Officer | 0 companies |
| Farhiya Alex Sellman | Deputy Chief Executive Officer | 0 companies |
| Carl Fredrik Gustaf Carlborg | Board of Directors | 0 companies |
| Lars-Erik Rudolf Wågberg | Board of Directors | 0 companies |
| Rebecca Anna Mikaela Östmans | Chairman | 0 companies |